Akso Health Group (China)

The Company is based on the innovation of health science and technology, creating the source of the comprehensive health industry chain, building medical health products, telemedicine, offline tumor treatment platforms, and vaccine research and development centers.
The Company has adopted an online and offline smart health management model, focusing on the development and implementation of the most valuable smart health management projects. Provide smart health management platform, home care and health management services in many fields such as finance.
The Company building a comprehensive medical and health system, and providing services such as a medical and health product mall (technology and products), a remote diagnosis and treatment platform, an offline tumor treatment platform, and vaccine research and development.
HISTORY
2014 The company was founded
2016The Company is a limited company incorporated under the laws of the Cayman Islands on April 25, 2016.
2017 On November 3, 2017, its ADSs commenced trading on the NASDAQ Global Market under the symbol “HX.”
2018 The Company completed the acquisition Musketeer Group Inc in August 9, 2018.
2019 Since October 2019, the Company has ceased to conduct its P2P business.
2020 On December 30, 2020, the Company completed the disposition transaction of its P2P business. The Company changed its name to Xiaobai Maimai Inc. On August 24, 2020. Its ADSs trade under the symbol “AHG.”
2021 The Company changed its name to “Akso Health Group”
2022 In February 2022, the Company started its business in the US market for the sale of medical devices.
2023 In May 2023, the Company disposed its social E-commerce business and would focus on healthcare business in the future.
2024 On April 30, 2024, the Company amended its authorized share capital, as result, the ordinary shares, par value US 0.0001 each, of the company were re-designated into Class A ordinary shares, par value US 0.0001 each, and Class B ordinary shares, par value US 0.0001 each.)